{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:49:44Z","timestamp":1783640984227,"version":"3.55.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,20]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Major orthopedic surgery, including hip and knee replacement and lower extremity trauma fractures surgery, is associated with a high risk of venous thromboembolism (VTE), especially proximal deep vein thrombosis (DVT), and pulmonary embolism (PE), and is linked with high morbidity and mortality rates. Chemical anticoagulation is routinely used to prevent VTE, with previous meta-analyses reporting on the efficacy and safety of aspirin and other anticoagulants, however, opinions are divided. In the past 2 years, several large randomized controlled trials have been published, therefore, we reanalyzed aspirin efficacy and safety when compared with other anticoagulants in preventing VTE in major orthopedic surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Using PubMed, The Cochrane Library, Embase, and Web of Science databases, we conducted a RCT search in August 2023. The main outcomes included VTE, proximal DVT or PE. Additional outcomes included bleeding events, wound complications, wound infections, blood transfusions, and death events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 17 eligible articles, involving 29,522 patients (15,253 aspirin vs 14,269 other anticoagulant cases), were included. Primary outcomes showed that VTE incidence was more high in the aspirin group when compared with other anticoagulants (risk ratio [RR]\u2005=\u20051.45, 95% confidence interval [CI]\u2005=\u20051.18\u20131.77, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0004) and proximal in the aspirin group the DVT and\/or PE incidence was significantly higher in the aspirin group when compared with other anticoagulants (RR\u2005=\u20051.19, 95% CI\u2005=\u20051.02\u20131.39, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.03). No significant secondary outcome differences were identified in the aspirin group when compared with other anticoagulants (bleeding events [RR]\u2005=\u20050.83, 95% CI\u2005=\u20050.63\u20131.10, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.20); wound complications (RR\u2005=\u20050.45, 95% CI\u2005=\u20050.20\u20131.04, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.06); wound infection (RR\u2005=\u20051.08, 95% CI\u2005=\u20050.85\u20131.38, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.53); blood transfusion events (RR\u2005=\u20051.00, 95% CI\u2005=\u20050.84\u20131.19, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20051.00) and death events (RR\u2005=\u20051.11, 95% CI\u2005=\u20050.78\u20131.57, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.55).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our updated meta-analysis showed that aspirin was inferior to when compared with other anticoagulants in VTE-related orthopedic major surgery, including proximal DVT and\/or PE, and was more likely to form VTE. No differences between groups were identified for bleeding, wound complications, wound infections, transfusion, or death events.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000035602","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T15:22:13Z","timestamp":1697815333000},"page":"e35602","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy and safety of aspirin in preventing venous thrombosis in major orthopedic surgery: An updated meta-analysis of randomized controlled trials"],"prefix":"10.1097","volume":"102","author":[{"given":"Heng-Zhi","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Department of Orthopaedics, Yichang Central People\u2019s Hospital, Yichang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Department of Orthopaedics, Yichang Central People\u2019s Hospital, Yichang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Xin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China"},{"name":"Department of Orthopaedics, Yichang Central People\u2019s Hospital, Yichang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1538-7836.2005.01621.x","article-title":"Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.","volume":"3","author":"Piovella","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jamasurg.2019.3742","article-title":"Risk of pulmonary embolism more than 6 weeks after surgery among cancer-free middle-aged patients.","volume":"154","author":"Caron","year":"2019","journal-title":"JAMA Surg"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.ajem.2018.09.027","article-title":"VTE ought to be divided not only in DVT and PTE, but also in subacute\/chronic forms.","volume":"37","author":"Koracevic","year":"2019","journal-title":"Am J Emerg Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/TA.0000000000003475","article-title":"American Association for the Surgery of Trauma\/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma.","volume":"92","author":"Yorkgitis","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.chest.2022.08.004","article-title":"Executive summary: perioperative management of antithrombotic therapy: an American College of Chest physicians clinical practice guideline.","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.","volume":"355","year":"2000","journal-title":"Lancet (London, England)"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1530\/EOR-22-0053","article-title":"Clinical effectiveness and safety of aspirin and other anticoagulants for venous thromboembolism prophylaxis after major orthopedic surgery: a systematic review and meta-analysis of randomized clinical trials.","volume":"7","author":"Singjie","year":"2022","journal-title":"EFORT Open Rev"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.2022.13416","article-title":"Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial.","volume":"328","author":"Sidhu","year":"2022","journal-title":"JAMA"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2205973","article-title":"Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture.","volume":"388","author":"O\u2019Toole","year":"2023","journal-title":"N Engl J Med"},{"key":"R12-20250504","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research ed)"},{"key":"R13-20250504","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochr Database Syst Rev"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty.","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med"},{"key":"R16-20250504","first-page":"163","article-title":"Comparative study between enoxaparin and salicylic acetyl acid in antithrombotic prophylaxis for patients undergoing total knee arthroplasty.","volume":"35","author":"Cortes-De la Fuente","year":"2021","journal-title":"Acta Ortop Mex"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/01.CIR.93.1.80","article-title":"Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.","volume":"93","author":"Gent","year":"1996","journal-title":"Circulation"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e0235628","DOI":"10.1371\/journal.pone.0235628","article-title":"Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: a patient-centered randomized controlled trial.","volume":"15","author":"Haac","year":"2020","journal-title":"PLoS One"},{"key":"R19-20250504","first-page":"741","article-title":"Aspirin versus rivaroxaban to prevent venous thromboembolism after total knee arthroplasty: a double-blinded, randomized controlled trial.","volume":"57","author":"Hongnaparak","year":"2022","journal-title":"Rev Bras Ortop (Sao Paulo)"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.arth.2013.05.025","article-title":"DVT prophylaxis after TKA: routine anticoagulation vs risk screening approach - a randomized study.","volume":"28","author":"Kulshrestha","year":"2013","journal-title":"J Arthroplasty"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00003086-199603000-00031","article-title":"Aspirin and warfarin for thromboembolic disease after total joint arthroplasty.","author":"Lotke","year":"1996","journal-title":"Clin Orthop Relat Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0883-5403(06)80067-7","article-title":"Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty.","volume":"7","author":"Paiement","year":"1992","journal-title":"J Arthroplasty"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archinte.1989.00390040013003","article-title":"A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.","volume":"149","author":"Powers","year":"1989","journal-title":"Arch Intern Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/CM9.0000000000001305","article-title":"Comparable efficacy of 100\u2009mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial.","volume":"134","author":"Ren","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"6 Suppl 2","key":"R25-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2006.05.017","article-title":"VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.","volume":"21","author":"Westrich","year":"2006","journal-title":"J Arthroplasty"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12891-022-06117-8","article-title":"Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study.","volume":"24","author":"Zhou","year":"2023","journal-title":"BMC Musculoskelet Disord"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MBC.0000000000000121","article-title":"Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty.","volume":"25","author":"Zou","year":"2014","journal-title":"Blood Coagul Fibrinol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2106\/00004623-199173040-00005","article-title":"Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin.","volume":"73","author":"Woolson","year":"1991","journal-title":"J Bone Joint Surg Am"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","article-title":"Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?","volume":"475","author":"Bala","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jhm.2224","article-title":"Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis.","volume":"9","author":"Drescher","year":"2014","journal-title":"J Hospital Med"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials.","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jor.2019.02.032","article-title":"Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: an updated meta-analysis of randomized controlled trials.","volume":"16","author":"Haykal","year":"2019","journal-title":"J Orthop"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/ans.15122","article-title":"Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.","volume":"89","author":"Nadi","year":"2019","journal-title":"ANZ J Surg"},{"key":"R34-20250504","first-page":"e36464","article-title":"Incidence of symptomatic venous thromboembolism (VTE) in 8,885 elective total hip arthroplasty patients receiving post-operative aspirin VTE prophylaxis.","volume":"15","author":"Coveney","year":"2023","journal-title":"Cureus"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"e0250096","DOI":"10.1371\/journal.pone.0250096","article-title":"Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.","volume":"16","author":"He","year":"2021","journal-title":"PLoS One"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"e23055","DOI":"10.1097\/MD.0000000000023055","article-title":"Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty: a protocol for meta-analysis.","volume":"99","author":"Le","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"102606","DOI":"10.1016\/j.otsr.2020.04.002","article-title":"Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.","volume":"107","author":"Farey","year":"2021","journal-title":"Orthop Traumatol Surg Res"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.knee.2019.01.004","article-title":"Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.","volume":"26","author":"Richardson","year":"2019","journal-title":"Knee"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.arth.2021.01.072","article-title":"Utilization patterns, efficacy, and complications of venous thromboembolism prophylaxis strategies in revision hip and knee arthroplasty as reported by American board of orthopaedic surgery part ii candidates.","volume":"36","author":"Runner","year":"2021","journal-title":"J Arthroplasty"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.arth.2018.12.015","article-title":"Utilization patterns, efficacy, and complications of venous thromboembolism prophylaxis strategies in primary hip and knee arthroplasty as reported by American board of orthopedic surgery part II candidates.","volume":"34","author":"Runner","year":"2019","journal-title":"J Arthroplasty"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jos.2019.02.009","article-title":"Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty.","volume":"25","author":"Mihara","year":"2020","journal-title":"J Orthop Sci"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/CORR.0000000000000613","article-title":"No difference between low- and regular-dose aspirin for venous thromboembolism prophylaxis after THA.","volume":"477","author":"Faour","year":"2019","journal-title":"Clin Orthop Relat Res"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.arth.2018.03.001","article-title":"Low-dose aspirin is safe and effective for venous thromboembolism prophylaxis following total knee arthroplasty.","volume":"33","author":"Faour","year":"2018","journal-title":"J Arthroplasty"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:29:14Z","timestamp":1746325754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":42,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035602","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]}}}